Proton Beam Radiation Therapy for Oropharyngeal Squamous Cell Carcinoma
暂无分享,去创建一个
A. Eisbruch | W. Mendenhall | P. Strojan | J. Beitler | A. Shaha | A. Ferlito | O. Cohen | S. Ng | S. Nuyts | W. Ng | R. Smee | J. Kirwan | H. Bollen | Nabil F. Saba
[1] A. Eisbruch,et al. Proton Therapy for Squamous Cell Carcinoma of the Head and Neck: Early Clinical Experience and Current Challenges , 2022, Cancers.
[2] N. Lee,et al. Evaluation of Substantial Reduction in Elective Radiotherapy Dose and Field in Patients With Human Papillomavirus-Associated Oropharyngeal Carcinoma Treated With Definitive Chemoradiotherapy. , 2022, JAMA oncology.
[3] P. Bondiau,et al. Optimizing oropharyngeal cancer management by using proton beam therapy: trends of cost-effectiveness , 2021, BMC Cancer.
[4] A. Garden,et al. Determinants of patient‐reported xerostomia among long‐term oropharyngeal cancer survivors , 2021, Cancer.
[5] W. Mendenhall,et al. Insurance Approval for Definitive Proton Therapy for Prostate Cancer , 2021, International journal of particle therapy.
[6] A. Garden,et al. Proton Therapy for HPV-Associated Oropharyngeal Cancers of the Head and Neck: a De-Intensification Strategy , 2021, Current Treatment Options in Oncology.
[7] A. Garden,et al. Activity-Based Costing of Intensity-Modulated Proton versus Photon Therapy for Oropharyngeal Cancer , 2021, International journal of particle therapy.
[8] A. Garden,et al. Work Outcomes after Intensity-Modulated Proton Therapy (IMPT) versus Intensity-Modulated Photon Therapy (IMRT) for Oropharyngeal Cancer , 2021, International journal of particle therapy.
[9] Steven J. Frank,et al. Cost-Effectiveness Models of Proton Therapy for Head and Neck: Evaluating Quality and Methods to Date , 2021, International journal of particle therapy.
[10] A. Garden,et al. Patient-Reported Outcomes after Intensity-Modulated Proton Therapy for Oropharynx Cancer , 2021, International journal of particle therapy.
[11] A. Garden,et al. Intensity-modulated proton therapy for oropharyngeal cancer reduces rates of late xerostomia. , 2021, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[12] J. Noh,et al. Early Clinical Outcomes of Intensity Modulated Radiation Therapy/Intensity Modulated Proton Therapy Combination in Comparison with Intensity Modulated Radiation Therapy Alone in Oropharynx Cancer Patients , 2021, Cancers.
[13] S. Kalnicki,et al. Individualized quality of life benefit and cost-effectiveness estimates of proton therapy for patients with oropharyngeal cancer , 2021, Radiation oncology.
[14] A. van der Schaaf,et al. Development of advanced preselection tools to reduce redundant plan comparisons in model-based selection of head and neck cancer patients for proton therapy. , 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[15] D. Mundy,et al. Evaluation of replanning in intensity-modulated proton therapy for oropharyngeal cancer: Factors influencing plan robustness. , 2020, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.
[16] D. Chang,et al. Second cancer risk after primary cancer treatment with three‐dimensional conformal, intensity‐modulated, or proton beam radiation therapy , 2020, Cancer.
[17] A. Lin,et al. Predicted Secondary Malignancies following Proton versus Photon Radiation for Oropharyngeal Cancers , 2020, International journal of particle therapy.
[18] A. Garden,et al. Prospective longitudinal patient-reported outcomes of swallowing following intensity modulated proton therapy for oropharyngeal cancer. , 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[19] Andrew G. Lee,et al. Clinical Outcomes and Toxicities in Oropharyngeal Cancer (OPC) Patients Treated with Proton Therapy: A Single Institutional Experience , 2020 .
[20] Jeffrey L. Anderson,et al. Comparative analysis of acute toxicities and patient reported outcomes between intensity-modulated proton therapy (IMPT) and volumetric modulated arc therapy (VMAT) for the treatment of oropharyngeal cancer. , 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[21] N. Iles,et al. TORPEdO - A Phase III Trial of Intensity-modulated Proton Beam Therapy Versus Intensity-modulated Radiotherapy for Multi-toxicity Reduction in Oropharyngeal Cancer. , 2020, Clinical oncology (Royal College of Radiologists (Great Britain)).
[22] J. Langendijk,et al. Reduced radiation-induced toxicity by using proton therapy for the treatment of oropharyngeal cancer. , 2020, The British journal of radiology.
[23] G. Laramore,et al. Proton Therapy for Locally Advanced Oropharyngeal Cancer: Initial Clinical Experience at the University of Washington. , 2019, International journal of particle therapy.
[24] C. Glastonbury,et al. Advances in Diagnosis and Multidisciplinary Management of Oropharyngeal Squamous Cell Carcinoma: State of the Art. , 2019, Radiographics : a review publication of the Radiological Society of North America, Inc.
[25] W. Mendenhall,et al. Insurance Coverage for Adjuvant Proton Therapy in the Definitive Treatment of Breast Cancer. , 2019, International journal of particle therapy.
[26] S. Kalnicki,et al. A Quantitative Clinical Decision-Support Strategy Identifying Which Patients With Oropharyngeal Head and Neck Cancer May Benefit the Most From Proton Radiation Therapy. , 2019, International journal of radiation oncology, biology, physics.
[27] N. Lester-Coll,et al. Modeling the Potential Benefits of Proton Therapy for Patients With Oropharyngeal Head and Neck Cancer. , 2019, International journal of radiation oncology, biology, physics.
[28] H. Kooy,et al. Impact of setup and range uncertainties on TCP and NTCP following VMAT or IMPT of oropharyngeal cancer patients , 2019, Physics in medicine and biology.
[29] J. Langendijk,et al. First experience with model-based selection of head and neck cancer patients for proton therapy. , 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[30] Reid F Thompson,et al. Quality of Life of Postoperative Photon versus Proton Radiation Therapy for Oropharynx Cancer , 2018, International journal of particle therapy.
[31] Nhat-Long Pham,et al. Cost-Effectiveness Analysis of Intensity Modulated Radiation Therapy Versus Proton Therapy for Oropharyngeal Squamous Cell Carcinoma. , 2018, International journal of radiation oncology, biology, physics.
[32] D. Hayes,et al. Mature results of a prospective study of deintensified chemoradiotherapy for low‐risk human papillomavirus‐associated oropharyngeal squamous cell carcinoma , 2018, Cancer.
[33] A. Garden,et al. Comparing Intensity-Modulated Proton Therapy With Intensity-Modulated Photon Therapy for Oropharyngeal Cancer: The Journey From Clinical Trial Concept to Activation. , 2018, Seminars in radiation oncology.
[34] Radhe Mohan,et al. Intensity-Modulated Proton Therapy Adaptive Planning for Patients with Oropharyngeal Cancer. , 2017, International journal of particle therapy.
[35] Kristin Stützer,et al. Superiority in Robustness of Multifield Optimization Over Single-Field Optimization for Pencil-Beam Proton Therapy for Oropharynx Carcinoma: An Enhanced Robustness Analysis. , 2017, International journal of radiation oncology, biology, physics.
[36] W. Mendenhall,et al. Rapid Radiation Therapy for Advanced Cancer of the Head and Neck #336. , 2017, Journal of palliative medicine.
[37] A. Garden,et al. Intensity-modulated proton therapy and osteoradionecrosis in oropharyngeal cancer. , 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[38] Nadeem Riaz,et al. Proton therapy for head and neck cancer: expanding the therapeutic window. , 2017, The Lancet. Oncology.
[39] A. Garden,et al. Dosimetric advantages of intensity-modulated proton therapy for oropharyngeal cancer compared with intensity-modulated radiation: A case-matched control analysis. , 2016, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.
[40] W. Mendenhall,et al. Ipsilateral radiotherapy for squamous cell carcinoma of the tonsil , 2016, European Archives of Oto-Rhino-Laryngology.
[41] Steven J Frank,et al. Intensity-Modulated Proton Therapy ( IMPT ) versus Intensity-Modulated Photon Radiotherapy ( IMRT ) for Oropharyngeal Cancer : First Comparative Results of Patient-Reported Outcomes , 2016 .
[42] Steven J Frank,et al. Intensity-modulated proton beam therapy (IMPT) versus intensity-modulated photon therapy (IMRT) for patients with oropharynx cancer - A case matched analysis. , 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[43] R. Mohan,et al. Clinical Outcomes and Patterns of Disease Recurrence After Intensity Modulated Proton Therapy for Oropharyngeal Squamous Carcinoma. , 2016, International journal of radiation oncology, biology, physics.
[44] Johannes A Langendijk,et al. Using a reduced spot size for intensity-modulated proton therapy potentially improves salivary gland-sparing in oropharyngeal cancer. , 2012, International journal of radiation oncology, biology, physics.
[45] Johannes A Langendijk,et al. Potential benefits of scanned intensity-modulated proton therapy versus advanced photon therapy with regard to sparing of the salivary glands in oropharyngeal cancer. , 2011, International journal of radiation oncology, biology, physics.
[46] Jonathan G. Li,et al. Intensity‐modulated radiotherapy for oropharyngeal squamous cell carcinoma 1 , 2010, The Laryngoscope.
[47] K. Ang,et al. Human papillomavirus and survival of patients with oropharyngeal cancer. , 2010, The New England journal of medicine.
[48] D. Moher,et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement , 2009, BMJ.
[49] D. Moher,et al. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement , 2009, BMJ : British Medical Journal.
[50] H. Christiansen,et al. Long-term follow-up after transoral laser microsurgery and adjuvant radiotherapy for advanced recurrent squamous cell carcinoma of the head and neck. , 2006, International journal of radiation oncology, biology, physics.
[51] Daniel W. Miller,et al. Proton radiation for treatment of cancer of the oropharynx: early experience at Loma Linda University Medical Center using a concomitant boost technique. , 2005, International journal of radiation oncology, biology, physics.
[52] Gwyn McClelland. Survivors , 1891, The Hospital.